Cargando…

Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas

SIMPLE SUMMARY: Assessing survival risk in patients with high-grade endometrial carcinomas has remained challenging. The aim of our retrospective study was to investigate the distribution of molecular subtypes and assess their prognostic role in patients with high-grade endometrial carcinoma. We fou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zong, Liju, Mo, Shengwei, Sun, Zezheng, Lu, Zhaohui, Chen, Jie, Yu, Shuangni, Xiang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866413/ https://www.ncbi.nlm.nih.gov/pubmed/36675462 http://dx.doi.org/10.3390/jcm12020530

Ejemplares similares

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study
por: Yu, Shuangni, et al.
Publicado: (2022)

A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms
por: Chen, Xianlong, et al.
Publicado: (2022)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022)

The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma
por: Ma, Heng, et al.
Publicado: (2023)

Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia
por: Cheng, Hongyan, et al.
Publicado: (2023)

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
por: Zhang, Yue, et al.
Publicado: (2022)

Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix
por: Zong, Liju, et al.
Publicado: (2020)

VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
por: Zong, Liju, et al.
Publicado: (2019)

Incorporation of molecular characteristics into endometrial cancer management
por: Vermij, Lisa, et al.
Publicado: (2019)

Role of Temozolomide Regimen on Survival Outcomes in Molecularly Stratified WHO Grade II Gliomas: A Systematic Review
por: Ghaffari-Rafi, Arash, et al.
Publicado: (2021)

Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis With Trial Sequential Analysis
por: Gu, Yu, et al.
Publicado: (2021)

Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma
por: Ma, Heng, et al.
Publicado: (2023)

Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay
por: Yu, Shuangni, et al.
Publicado: (2019)

Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification
por: Lin, Yi-Hua, et al.
Publicado: (2016)

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
por: Kommoss, Felix KF, et al.
Publicado: (2018)

Endometrial cancer: molecular classification and future treatments
por: Corr, Bradley, et al.
Publicado: (2022)

Molecular pathogenesis and prognostication of "low‐grade'' and "high‐grade" endometrial stromal sarcoma
por: Micci, Francesca, et al.
Publicado: (2020)

Risk Stratified Follow-Up for Endometrial Cancer: The Clinicians’ Perspective
por: Amirthanayagam, Anumithra, et al.
Publicado: (2023)

Molecular classification grade 3 endometrial endometrioid carcinoma using a next-generation sequencing–based gene panel
por: Li, Ling, et al.
Publicado: (2022)

Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer
por: Thurtle, David, et al.
Publicado: (2016)

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
por: Vrede, Stephanie W., et al.
Publicado: (2022)

Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia
por: Puechl, Allison M., et al.
Publicado: (2021)

Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications
por: Internò, Valeria, et al.
Publicado: (2022)

A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers
por: Li, Yang, et al.
Publicado: (2022)

Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)

Guideline concordant therapy improves survival in high-grade endometrial cancer patients
por: Scharl, Sophia, et al.
Publicado: (2022)

A clinically applicable molecular-based classification for endometrial cancers
por: Talhouk, A, et al.
Publicado: (2015)

Molecular classification of endometrial cancer: entering an era of precision medicine
por: Goulder, Alison, et al.
Publicado: (2022)

Molecular Classification of Endometrial Carcinoma: Protocol for a Cohort Study
por: Moreira, Inês, et al.
Publicado: (2022)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

The role of TCGA molecular classification in clear cell endometrial carcinoma
por: Tang, Xinyue, et al.
Publicado: (2023)

High-Grade Glioma: Refined Diagnostics Steering Stratified Therapy
por: Uhl, Martin, et al.
Publicado: (2013)

Clinical Features of Crohn’s Disease Stratified by Age at Diagnosis According to Montreal Classification
por: Xiang, Jiankang, et al.
Publicado: (2023)

“If Not Us, Then Who? If Not Now, Then When?” - The Need for Resource Stratified Guidelines
por: Bhatnagar, Sushma
Publicado: (2016)

Endometrial Assessment: When is it Necessary?
por: Pessoa, Juliana Nicoletti, et al.
Publicado: (2014)

Essential oil-incorporated carbon nanotubes filters for bacterial removal and inactivation
por: Dong, Xiuli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nhhr8els5kubotp2pp195tpkof